SNORD62A

Across TCGA pan-cancer cohorts, SNORD62A RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SNORD62A data layer.

The strongest signal is observed in mesothelioma (MESO), where higher SNORD62A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD62A expression acts as an unfavorable survival marker, although some lineages such as LAML and GBM show a favorable association.

MESO, SKCM, and CHOL are the cancer types where SNORD62A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.362	0.629	<.001	140	view →
SKCM	OS	Tertile	II,III,IV	0.175	0.436	<.001	44	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
LAML	DFS	Quartile	All	0.668	0.241	.006	18	view →
LIHC	DFS	Tertile	All	0.401	0.581	.006	18	view →
KIRC	DFS	Median	IV	0.229	0.453	.014	18	view →
THCA	OS	Tertile	IV	0.813	1.000	.039	15	view →
GBM	DFS	Tertile	All	0.263	0.160	.007	12	view →
COAD	DFS	Tertile	All	0.810	0.641	.022	9	view →
LGG	DFS	Quartile	All	0.233	0.523	.004	7	view →
UCS	OS	Quartile	III,IV	0.847	0.506	.028	6	view →
STAD	DFS	Quartile	III,IV	0.786	0.420	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SNORD62A–MESO (OS)

Open the MESO breakdown →